Literature DB >> 22721863

Nectin 4 is the epithelial cell receptor for measles virus.

Ryan S Noyce1, Christopher D Richardson.   

Abstract

Measles virus (MV) causes acute respiratory disease, infects lymphocytes and multiple organs, and produces immune suppression leading to secondary infections. In rare instances it can also cause persistent infections in the brain and central nervous system. Vaccine and laboratory-adapted strains of MV use CD46 as a receptor, whereas wild-type strains of MV (wtMV) cannot. Both vaccine and wtMV strains infect lymphocytes, monocytes, and dendritic cells (DCs) using the signaling lymphocyte activation molecule (CD150/SLAM). In addition, MV can infect the airway epithelial cells of the host. Nectin 4 (PVRL4) was recently identified as the epithelial cell receptor for MV. Coupled with recent observations made in MV-infected macaques, this discovery has led to a new paradigm for how the virus accesses the respiratory tract and exits the host. Nectin 4 is also a tumor cell marker which is highly expressed on the apical surface of many adenocarcinoma cell lines, making it a potential target for MV oncolytic therapy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721863     DOI: 10.1016/j.tim.2012.05.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  51 in total

1.  Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.

Authors:  Yu-Ping Liu; Samuel P Russell; Camilo Ayala-Breton; Stephen J Russell; Kah-Whye Peng
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 2.  Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity.

Authors:  Dibyendu Samanta; Steven C Almo
Journal:  Cell Mol Life Sci       Date:  2014-10-19       Impact factor: 9.261

3.  Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.

Authors:  Yuan Qi; Kailin Xing; Lanlin Zhang; Fangyu Zhao; Ming Yao; Aiqun Hu; Xianghua Wu
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-06       Impact factor: 4.553

4.  The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway Epithelia.

Authors:  Brajesh K Singh; Andrew L Hornick; Sateesh Krishnamurthy; Anna C Locke; Crystal A Mendoza; Mathieu Mateo; Catherine L Miller-Hunt; Roberto Cattaneo; Patrick L Sinn
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  Dimerization Efficiency of Canine Distemper Virus Matrix Protein Regulates Membrane-Budding Activity.

Authors:  Fanny Bringolf; Michael Herren; Marianne Wyss; Beatriz Vidondo; Johannes P Langedijk; Andreas Zurbriggen; Philippe Plattet
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

6.  C Protein is Essential for Canine Distemper Virus Virulence and Pathogenicity in Ferrets.

Authors:  Oliver Siering; Bevan Sawatsky; Christian K Pfaller
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

Review 7.  The biology and rationale of targeting nectin-4 in urothelial carcinoma.

Authors:  Elisabeth I Heath; Jonathan E Rosenberg
Journal:  Nat Rev Urol       Date:  2020-11-25       Impact factor: 14.432

Review 8.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 9.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

10.  MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.

Authors:  Hirosha Geekiyanage; Evanthia Galanis
Journal:  Mol Oncol       Date:  2016-07-28       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.